Platelets are behind the cognitive benefits of young blood, exercise and the longevity hormone klotho
A legendary biotech investor warns that shorting industry stocks isn’t easy
SAN FRANCISCO — “No one ever got really rich shorting stocks,” said Joe Edelman, the founder and CEO of Perceptive Advisors, a $7.5 billion biotech